Evidence map›Paper›PMID 38203775›Full record

ArticleInternational journal of molecular sciences2024

A Common Polymorphism in

Raul Anguita, Guillem Prats-Ejarque, Mohammed Moussaoui, Brian Becknell, Ester Boix

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Raul AnguitaDepartment of Biochemistry and Molecular Biology, Faculty of Biosciences, Universitat Autònoma de Barcelona, 08193 Cerdanyola del Vallès, Spain.ORCID 0000-0003-2491-4811
Guillem Prats-EjarqueDepartment of Biochemistry and Molecular Biology, Faculty of Biosciences, Universitat Autònoma de Barcelona, 08193 Cerdanyola del Vallès, Spain.ORCID 0000-0002-8213-4947
Mohammed MoussaouiDepartment of Biochemistry and Molecular Biology, Faculty of Biosciences, Universitat Autònoma de Barcelona, 08193 Cerdanyola del Vallès, Spain.
Brian BecknellKidney and Urinary Tract Center, The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH 43205, USA.
Ester BoixDepartment of Biochemistry and Molecular Biology, Faculty of Biosciences, Universitat Autònoma de Barcelona, 08193 Cerdanyola del Vallès, Spain.ORCID 0000-0003-1790-2142
Universitat Autònoma de Barcelona · ESNationwide Children's Hospital · US

Funding

Roles and Regulation of Ribonuclease 6 in Defending the Urinary Tract Against Bacterial InfectionR03DK118306 · NIDDK · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI BECKNELL, BRIAN · 2018 to 2019
$228k
NIDDK NIH HHS R03 DK118306
6 · The paper itself

Abstract

Human Ribonuclease (RNase) 6 is a monocyte and macrophage-derived protein with potent antimicrobial activity toward uropathogenic bacteria. The

Indexed as

Anti-Infective AgentsUropathogenic Escherichia coliAllelesHumansPolymorphism, Single NucleotideRibonucleasesAnti-Infective AgentsRibonucleasesantimicrobial peptidesRNaseRNase 6RNase k6single nucleotide polymorphismsurinary tract infectionsuropathogenic Escherichia coli

Identifiers

PMID38203775
PMCPMC10779065
OpenAlexW4390543226

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.